Posttransplant lymphoproliferative disorders are often accompanied by >500
Epstein-Barr virus (EBV) genome copies/10(5) lymphocytes, and they occur sh
ortly after transplantation. Hodgkin lymphoma occurs rarely after transplan
tation, appearing a mean of 4.2 years posttransplant, and although Hodgkin
lymphoma has strong associations with EBV, no quantitative analysis of peri
pheral blood EBV genome copies has been reported. A mixed cellularity Hodgk
in lymphoma developed in a 17-year-old boy 4 years after a renal transplant
. Serial EBV genome copy numbers from blood by competitive polymerase chain
reaction had been obtained to assess for lymphoproliferative disease. Epst
ein-Barr virus genome copy numbers peaked at 500 copies/10(5) lymphocytes 8
months prior to Hodgkin lymphoma diagnosis but fell to 8 copies/10(5) lymp
hocytes at diagnosis. Reliance on EBV levels greater than 500 copies may re
sult in delay of biopsy and diagnosis of Hodgkin disease in the posttranspl
ant setting.